Intelligene Inc. (7832.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$14.05 (-2.43%) as of
Key statistics
- Market cap
- 8.15B
- EPS (TTM)
- -0.19
- Dividend yield
- 0.00%
- 52-week range
- 10.80 – 17.65
- Revenue (TTM)
- 796k
- Profit margin
- 0.00%
- Volume
- 288.92k
About Intelligene Inc.
Intelligene Inc. engages in the research and development of RNA gene therapy drugs in Taiwan and Australia. The company offers IG-001, a siRNA-based drug which is under preclinical trials for the treatment of coronavirus disease; and IG-002, a siRNA-based drug which is under drug screening for the treatment of influenza. It also provides lipid nanoparticle and exosome drug encapsulation technologies to customize drug carriers and develop nucleic acid therapeutics. The company was founded in 2023 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.